Report cover image

Generative AI in Product Design & Engineering Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034

Published Jul 24, 2026
Length 180 Pages
SKU # FOB21420462

Description

Growth Factors of Generative AI in Product Design & Engineering Market

The global Generative AI in Product Design & Engineering Market is witnessing significant growth as industries increasingly adopt artificial intelligence-driven solutions to automate design processes, optimize engineering workflows, and accelerate product development cycles. The global market size was valued at USD 5.69 billion in 2025 and is projected to reach USD 7.02 billion in 2026, further expanding to USD 39.12 billion by 2034, registering a CAGR of 24.0% during the forecast period from 2026 to 2034.

North America dominated the Generative AI in Product Design & Engineering Market Share in 2025, accounting for 38.48% of the global market, supported by strong AI infrastructure, advanced manufacturing capabilities, and the presence of leading engineering software providers.

Generative AI in product design and engineering refers to the use of artificial intelligence models capable of creating, optimizing, simulating, and validating engineering designs. These technologies support generative geometry creation, AI-powered lightweighting, automated assemblies, concept generation, simulation optimization, and digital engineering workflows.

The increasing adoption of smart manufacturing, Industry 4.0 technologies, cloud-based engineering platforms, and AI-enabled CAD/CAE solutions is driving the expansion of the Generative AI in Product Design & Engineering Industry Report. Major companies are focusing on partnerships, cloud platform expansion, and AI-native technology development to strengthen their market position.

Market Definition and Scope

Generative AI in Product Design & Engineering involves advanced AI algorithms that assist engineers and designers in developing optimized product concepts, improving simulation accuracy, reducing material usage, and accelerating product lifecycle management.

The technology enables automated design exploration by generating multiple design alternatives based on specific engineering requirements such as weight reduction, strength improvement, cost optimization, and sustainability goals.

The market scope includes AI-powered software platforms, engineering services, cloud-based solutions, and AI integration tools used across industries such as automotive, aerospace & defense, industrial machinery, consumer electronics, energy & power, marine & shipbuilding, robotics, and automation.

The growing demand for sustainable product development and digital transformation is creating new opportunities for Generative AI Market Growth across global engineering ecosystems.

Market Dynamics

Market Drivers

Increasing Adoption of Cloud-Based GPU and High-Performance Computing Infrastructure

The availability of scalable cloud-based GPU computing is one of the major factors supporting the growth of the Generative AI in Product Design & Engineering Market Forecast. Generative AI applications require significant computing power for complex simulations, optimization processes, and large-scale design generation.

Cloud platforms provide enterprises access to advanced computing resources without requiring large upfront investments in hardware infrastructure. High-performance computing capabilities allow engineers to perform real-time simulations, collaborate globally, and shorten product development timelines.

Automotive, aerospace, and industrial manufacturing companies are increasingly adopting cloud-based AI engineering platforms to improve efficiency and reduce development costs.

Market Trends

Growing Demand for AI Copilots in Engineering Workflows

AI copilots are emerging as a major trend in the Generative AI in Product Design & Engineering Market Trends. These intelligent assistants enable engineers to interact with design platforms through natural language commands, automate repetitive tasks, identify design issues, and optimize engineering decisions.

AI copilots improve productivity by assisting with modeling, simulation analysis, and design recommendations. They reduce dependency on specialized expertise and enable organizations to accelerate innovation.

Companies such as Autodesk, Siemens, and other engineering software providers are integrating AI assistants into CAD, CAE, and PLM platforms to enhance workflow automation.

Market Restraints

Complexity of Legacy CAD and PLM System Integration

The integration of generative AI solutions with existing CAD, CAE, and PLM systems remains a major challenge. Many enterprises operate legacy engineering environments that lack compatibility with modern AI-powered platforms.

Organizations often require customized connectors, workflow modifications, and additional investments to integrate AI technologies into existing systems. Data security concerns and migration challenges further limit adoption among some enterprises.

Market Opportunities

Sustainable and Circular Product Design Adoption

Sustainability initiatives are creating significant opportunities for the Generative AI in Product Design & Engineering Market Growth. AI-based design tools help engineers minimize material usage, develop lightweight structures, and identify environmentally friendly alternatives.

Industries such as automotive, aerospace, and electronics are using generative AI to design energy-efficient products and support circular economy objectives.

Market Challenges

Fragmented Multi-Vendor Engineering Ecosystems

The presence of multiple CAD, CAE, and PLM vendors creates interoperability challenges. Engineering organizations often use different software platforms, making seamless AI integration difficult.

Ensuring compatibility between design files, simulation data, and product lifecycle information increases implementation complexity and slows enterprise-wide adoption.

Impact of COVID-19

The COVID-19 pandemic initially affected engineering and manufacturing industries due to supply chain disruptions and project delays. However, accelerated digital transformation and remote engineering requirements increased demand for cloud-based design platforms and AI-powered collaboration tools.

Post-pandemic, industries have increased investments in automation, digital twins, and intelligent engineering solutions, supporting long-term growth of the Generative AI in Product Design & Engineering Market.

Segmentation Analysis

By Type

The market is segmented into software and services.

The software segment dominates the market due to increasing adoption of AI-enabled CAD, CAE, PLM platforms, simulation automation tools, and AI-powered optimization solutions.

Engineering organizations are investing heavily in standalone generative design platforms and embedded AI modules to improve product development efficiency.

The services segment is expected to experience strong growth as enterprises require AI customization, integration services, cloud deployment support, and workflow transformation solutions.

By Deployment Model

The market is divided into cloud-based, on-premise, and hybrid deployment models.

The cloud-based segment leads the Generative AI in Product Design & Engineering Market Share due to scalability, flexibility, lower infrastructure requirements, and improved collaboration capabilities.

Cloud deployment enables enterprises to access advanced computing resources for simulations, digital twins, and AI-driven product optimization.

By End Use Industry

The market includes automotive, aerospace & defense, industrial machinery, consumer electronics, energy & power, marine & shipbuilding, robotics & automation, and others.

The automotive segment dominates the market due to rising adoption of AI-powered lightweighting, battery optimization, aerodynamic design, and rapid prototyping solutions.

The robotics and automation segment is expected to witness strong growth due to increasing adoption of intelligent robots, Industry 4.0, and smart manufacturing technologies.

Regional Insights

North America

North America held the leading position in the Generative AI in Product Design & Engineering Market Size in 2025. The region accounted for 38.48% market share, supported by strong AI investments, advanced manufacturing infrastructure, and the presence of major technology companies.

The U.S. market is expected to reach USD 2.33 billion in 2026, driven by AI research, engineering software innovation, and adoption across automotive, aerospace, and defense industries.

Europe

Europe represents a mature market supported by strong automotive, aerospace, and industrial manufacturing sectors. Germany, France, and the U.K. are adopting generative AI solutions to improve sustainable product design and comply with environmental regulations.

Germany’s market is expected to reach USD 0.40 billion in 2026, while the U.K. market is projected to reach USD 0.29 billion in 2026.

Asia Pacific

Asia Pacific is expected to witness the fastest growth due to rapid industrialization, smart manufacturing initiatives, and increasing AI adoption.

China is projected to reach USD 0.80 billion in 2026, while India’s market is expected to reach USD 0.46 billion in 2026.

South America

South America is gradually adopting generative AI technologies across automotive, energy, and industrial sectors. Brazil is expected to reach USD 0.20 billion in 2026.

Middle East & Africa

The region is experiencing increasing adoption due to investments in smart cities, advanced manufacturing, aerospace, and energy projects.

Competitive Landscape

The Generative AI in Product Design & Engineering Market Analysis is highly competitive, with companies focusing on AI integration, partnerships, acquisitions, and cloud-based platform development.

Key companies operating in the market include:
  • Autodesk
  • Dassault Systèmes
  • Siemens Digital Industries Software
  • PTC
  • Ansys
  • Altair Engineering
  • NVIDIA
  • nTopology
  • Hexagon
  • Neural Concept
Companies are expanding AI capabilities within CAD, CAE, PLM, and simulation platforms to strengthen their global market presence.

Report Coverage

The Generative AI in Product Design & Engineering Market Report provides detailed analysis of market size, market forecast, industry trends, growth drivers, restraints, opportunities, segmentation analysis, regional outlook, competitive landscape, technological advancements, partnerships, acquisitions, and recent industry developments.

The report covers market values for 2025, 2026, and 2034, providing insights into future growth opportunities across global engineering industries.

Conclusion

The global Generative AI in Product Design & Engineering Market is expected to witness strong expansion, growing from USD 5.69 billion in 2025 to USD 39.12 billion by 2034. Increasing adoption of AI-powered design platforms, cloud-based computing infrastructure, smart manufacturing technologies, and sustainable product development strategies will remain key factors driving market growth.

Automotive, aerospace, robotics, and industrial manufacturing sectors are expected to remain major contributors as organizations focus on reducing development time, improving product performance, and optimizing resources. Although challenges such as legacy system integration and interoperability remain, continuous advancements in AI models, engineering software platforms, and digital transformation initiatives will create significant opportunities for the future of the Generative AI in Product Design & Engineering Market Outlook.

ATTRIBUTE DETAILS

Study Period 2021-2034

Base Year 2025

Forecast Period 2026-2034

Historical Period 2021-2024

Growth Rate CAGR of 24.0% from 2026-2034

Unit Value (USD Billion)

Segmentation By Type, Deployment Model, End Use Industry, and Region

By Type
  • Software
Standalone Design Platforms

AI Modules Embedded in CAD/CAE/PLM

AI Simulation Automation Tools

AI-powered Optimization Tools

AI Co-pilots for Engineers

3D Generative Model Engines
  • Services
AI Model Customization

Integration Services
  • Cloud Deployment & Optimization
  • AI Engineering Workflow Implementation
By Deployment Model
  • Cloud-based
    • On-Premise
    • Hybrid Deployment
    By End Use Industry
  • Automotive
    • Aerospace & Defense
    • Industrial Machinery & Manufacturing
    • Consumer Electronics
    • Energy & Power
    • Marine & Shipbuilding
    • Robotics & Automation
    • Others (Medical Devices, etc.)
    By Region
    • North America (By Type, By Deployment Model, By End Use Industry, and Country)
    U.S.

    By Deployment Model (USD)

    Canada

    By Deployment Model (USD)

    Mexico

    By Deployment Model (USD)
    • Europe (By Type, By Deployment Model, By End Use Industry, and Country/Sub-region)
    Germany

    By Deployment Model (USD)

    U.K.

    By Deployment Model (USD)

    Spain

    By Deployment Model (USD)

    France

    By Deployment Model (USD)

    Italy

    By Deployment Model (USD)

    BENELUX

    By Deployment Model (USD)

    Nordics

    By Deployment Model (USD)

    Russia

    By Deployment Model (USD)

    Rest of Europe
    • Asia Pacific (By Type, By Deployment Model, By End Use Industry, and Country/Sub-region)
    China

    By Deployment Model (USD)

    Japan

    By Deployment Model (USD)

    India

    By Deployment Model (USD)

    South Korea

    By Deployment Model (USD)

    ASEAN

    By Deployment Model (USD)

    Oceania

    By Deployment Model (USD)

    Rest of Asia Pacific
    • South America (By Type, By Deployment Model, By End Use Industry, and Country/Sub-region)
    Brazil

    By Deployment Model (USD)

    Argentina

    By Deployment Model (USD)

    Rest of South America
    • Middle East & Africa (By Type, By Deployment Model, By End Use Industry, and Country/Sub-region)
    GCC Countries

    By Deployment Model (USD)

    South Africa

    By Deployment Model (USD)

    Rest of Middle East & Africa

    Please Note: It will take 3 business days to complete the report upon order confirmation.

    Table of Contents

    180 Pages
    1. Introduction
    1.1. Research Scope
    1.2. Market Segmentation
    1.3. Research Methodology
    1.4. Definitions and Assumptions
    2. Executive Summary
    3. Market Dynamics
    3.1. Market Drivers
    3.2. Market Restraints
    3.3. Market Opportunities
    3.4. Market Trends
    4. Key Insights
    4.1. Technological Advancements in Personalized Medicine
    4.2. Prevalence of Key Diseases, By Key Countries/Regions, 2025
    4.3. Regulatory & Reimbursement Scenario, By Key Countries/Regions
    4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
    4.5. New Product Launches, By Key Players
    5. Global Personalized Medicine Market Analysis, Insights and Forecast, 2021-2034
    5.1. Market Analysis, Insights and Forecast – By Offering
    5.1.1. Diagnostics & Testing
    5.1.2. Therapeutics
    5.1.3. Software & Data Analytics
    5.1.4. Others
    5.2. Market Analysis, Insights and Forecast – By Technology
    5.2.1. Genomics & Molecular Testing
    5.2.2. Pharmacogenomics
    5.2.3. Biomarker-Based Profiling
    5.2.4. Liquid Biopsy
    5.2.5. Clinical Decision Support & Interpretation Software
    5.2.6. Others
    5.3. Market Analysis, Insights and Forecast – By Application
    5.3.1. Oncology
    5.3.2. Rare & Genetic Diseases
    5.3.3. Neurology
    5.3.4. Cardiology
    5.3.5. Infectious Diseases
    5.3.6. Others
    5.4. Market Analysis, Insights and Forecast – By End User
    5.4.1. Hospitals
    5.4.2. Specialty Clinics
    5.4.3. Diagnostic Laboratories
    5.4.4. Academic & Research Institutes
    5.4.5. Pharmaceutical & Biotechnology Companies
    5.4.6. Others
    5.5. Market Analysis, Insights and Forecast – Region
    5.5.1. North America
    5.5.2. Europe
    5.5.3. Asia Pacific
    5.5.4. Latin America
    5.5.5. Middle East & Africa
    6. North America Personalized Medicine Market Analysis, Insights and Forecast, 2021-2034
    6.1. Market Analysis, Insights and Forecast – By Offering
    6.1.1. Diagnostics & Testing
    6.1.2. Therapeutics
    6.1.3. Software & Data Analytics
    6.1.4. Others
    6.2. Market Analysis, Insights and Forecast – By Technology
    6.2.1. Genomics & Molecular Testing
    6.2.2. Pharmacogenomics
    6.2.3. Biomarker-Based Profiling
    6.2.4. Liquid Biopsy
    6.2.5. Clinical Decision Support & Interpretation Software
    6.2.6. Others
    6.3. Market Analysis, Insights and Forecast – By Application
    6.3.1. Oncology
    6.3.2. Rare & Genetic Diseases
    6.3.3. Neurology
    6.3.4. Cardiology
    6.3.5. Infectious Diseases
    6.3.6. Others
    6.4. Market Analysis, Insights and Forecast – By End User
    6.4.1. Hospitals
    6.4.2. Specialty Clinics
    6.4.3. Diagnostic Laboratories
    6.4.4. Academic & Research Institutes
    6.4.5. Pharmaceutical & Biotechnology Companies
    6.4.6. Others
    6.5. Market Analysis, Insights and Forecast – By Country
    6.5.1. U.S.
    6.5.2. Canada
    7. Europe Personalized Medicine Market Analysis, Insights and Forecast, 2021-2034
    7.1. Market Analysis, Insights and Forecast – By Offering
    7.1.1. Diagnostics & Testing
    7.1.2. Therapeutics
    7.1.3. Software & Data Analytics
    7.1.4. Others
    7.2. Market Analysis, Insights and Forecast – By Technology
    7.2.1. Genomics & Molecular Testing
    7.2.2. Pharmacogenomics
    7.2.3. Biomarker-Based Profiling
    7.2.4. Liquid Biopsy
    7.2.5. Clinical Decision Support & Interpretation Software
    7.2.6. Others
    7.3. Market Analysis, Insights and Forecast – By Application
    7.3.1. Oncology
    7.3.2. Rare & Genetic Diseases
    7.3.3. Neurology
    7.3.4. Cardiology
    7.3.5. Infectious Diseases
    7.3.6. Others
    7.4. Market Analysis, Insights and Forecast – By End User
    7.4.1. Hospitals
    7.4.2. Specialty Clinics
    7.4.3. Diagnostic Laboratories
    7.4.4. Academic & Research Institutes
    7.4.5. Pharmaceutical & Biotechnology Companies
    7.4.6. Others
    7.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
    7.5.1. U.K.
    7.5.2. Germany
    7.5.3. France
    7.5.4. Italy
    7.5.5. Spain
    7.5.6. Scandinavia
    7.5.7. Rest of Europe
    8. Asia Pacific Personalized Medicine Market Analysis, Insights and Forecast, 2021-2034
    8.1. Market Analysis, Insights and Forecast – By Offering
    8.1.1. Diagnostics & Testing
    8.1.2. Therapeutics
    8.1.3. Software & Data Analytics
    8.1.4. Others
    8.2. Market Analysis, Insights and Forecast – By Technology
    8.2.1. Genomics & Molecular Testing
    8.2.2. Pharmacogenomics
    8.2.3. Biomarker-Based Profiling
    8.2.4. Liquid Biopsy
    8.2.5. Clinical Decision Support & Interpretation Software
    8.2.6. Others
    8.3. Market Analysis, Insights and Forecast – By Application
    8.3.1. Oncology
    8.3.2. Rare & Genetic Diseases
    8.3.3. Neurology
    8.3.4. Cardiology
    8.3.5. Infectious Diseases
    8.3.6. Others
    8.4. Market Analysis, Insights and Forecast – By End User
    8.4.1. Hospitals
    8.4.2. Specialty Clinics
    8.4.3. Diagnostic Laboratories
    8.4.4. Academic & Research Institutes
    8.4.5. Pharmaceutical & Biotechnology Companies
    8.4.6. Others
    8.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
    8.5.1. China
    8.5.2. Japan
    8.5.3. India
    8.5.4. Australia
    8.5.5. Southeast Asia
    8.5.6. Rest of Asia Pacific
    9. Latin America Personalized Medicine Market Analysis, Insights and Forecast, 2021-2034
    9.1. Market Analysis, Insights and Forecast – By Offering
    9.1.1. Diagnostics & Testing
    9.1.2. Therapeutics
    9.1.3. Software & Data Analytics
    9.1.4. Others
    9.2. Market Analysis, Insights and Forecast – By Technology
    9.2.1. Genomics & Molecular Testing
    9.2.2. Pharmacogenomics
    9.2.3. Biomarker-Based Profiling
    9.2.4. Liquid Biopsy
    9.2.5. Clinical Decision Support & Interpretation Software
    9.2.6. Others
    9.3. Market Analysis, Insights and Forecast – By Application
    9.3.1. Oncology
    9.3.2. Rare & Genetic Diseases
    9.3.3. Neurology
    9.3.4. Cardiology
    9.3.5. Infectious Diseases
    9.3.6. Others
    9.4. Market Analysis, Insights and Forecast – By End User
    9.4.1. Hospitals
    9.4.2. Specialty Clinics
    9.4.3. Diagnostic Laboratories
    9.4.4. Academic & Research Institutes
    9.4.5. Pharmaceutical & Biotechnology Companies
    9.4.6. Others
    9.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
    9.5.1. Brazil
    9.5.2. Mexico
    9.5.3. Rest of Latin America
    10. Middle East & Africa Personalized Medicine Market Analysis, Insights and Forecast, 2021-2034
    10.1. Market Analysis, Insights and Forecast – By Offering
    10.1.1. Diagnostics & Testing
    10.1.2. Therapeutics
    10.1.3. Software & Data Analytics
    10.1.4. Others
    10.2. Market Analysis, Insights and Forecast – By Technology
    10.2.1. Genomics & Molecular Testing
    10.2.2. Pharmacogenomics
    10.2.3. Biomarker-Based Profiling
    10.2.4. Liquid Biopsy
    10.2.5. Clinical Decision Support & Interpretation Software
    10.2.6. Others
    10.3. Market Analysis, Insights and Forecast – By Application
    10.3.1. Oncology
    10.3.2. Rare & Genetic Diseases
    10.3.3. Neurology
    10.3.4. Cardiology
    10.3.5. Infectious Diseases
    10.3.6. Others
    10.4. Market Analysis, Insights and Forecast – By End User
    10.4.1. Hospitals
    10.4.2. Specialty Clinics
    10.4.3. Diagnostic Laboratories
    10.4.4. Academic & Research Institutes
    10.4.5. Pharmaceutical & Biotechnology Companies
    10.4.6. Others
    10.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
    10.5.1. GCC
    10.5.2. South Africa
    10.5.3. Rest of the Middle East & Africa
    11. Competitive Analysis
    11.1. Global Market Share Analysis (2025)
    11.2. Company Profiles (Overview, Products & Services, SWOT analysis, Recent developments, strategies, financials (based on availability)
    11.2.1. F. Hoffmann-La Roche Ltd
    11.2.2. Myriad Genetics, Inc.
    11.2.3. Thermo Fisher Scientific Inc.
    11.2.4. AstraZeneca
    11.2.5. Guardant Health, Inc.
    11.2.6. Agilent Technologies Inc.
    11.2.7. Pfizer Inc.
    11.2.8. Novartis AG
    11.2.9. Illumina Inc.
    11.2.10. Bristol-Myers Squibb Company
    How Do Licenses Work?
    Request A Sample
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.